Ferroptosis and autophagy-related genes contribute to hypertrophic cardiomyopathy progression Authors: Aiai Zhang, Wei Liu, Meiling Du, Feixing Li, Mengyang Yi, Huixian Li, Zhiwei Yang, Fangjiang Li Published: 2025 ABSTRACT We aimed to investigate the ferroptosis- and autophagy-related differentially expressed genes (DEGs) that might be potential targets for hypertrophic cardiomyopathy (HCM) progression.GSE89714 and ferroptosis- and autophagy databases were utilized to obtain the overlapping ferroptosis- and autophagy-related DEGs. Enrichment pathway analysis was performed and the hub genes were obtained. The HCM mice model, macrophage cell Line and single-cell sequencing data were used to validate the hub genes. Utilizing the Limma package and Venn diagram, 25 ferroptosis-related and 47 autophagy-related DEGs were obtained. They were mainly enriched in autophagy, ferroptosis, neurodegeneration pathways, multiple diseases, processes utilizing autophagic mechanisms, hijacked molecular function, and antioxidant activity. In the protein-protein interaction network, the hub DEGs, including BCL2L1, CD44, IGF1, CDKN1B, APP, CTNNB1, HMGB1, LAMP1, TFRC, and CXCR4 were obtained. Using a single-cell portal, sequencing of hub gene expression demonstrated that the hub genes were highly expressed in macrophages in the human and HCM hearts. The screened hub genes, BCL2L1, CD44, IGF1, CDKN1B, APP, CTNNB1, HMGB1, LAMP1, TFRC, and CXCR4, may be therapeutic targets for diagnosing HCM and its progression.Supplementary InformationThe online version contains supplementary material available at 10.1038/s41598-025-19206-0. Introduction HCM is a genetic disease of the myocardium arising from mutations in genes encoding proteins, of which prevalence is close to 0.5% in the general population1,2. HCM results in a risk of adverse events, for example, atrial fibrillation, stroke and sudden cardiac death. Young myocardial infarction (MI) patients with type 2 diabetes develop higher long-term cardiovascular-related mortality and over one-third die within 10 years3. Because the myocardium also hypertrophies in response to more prevalent stresses such as hypertension and aortic valve stenosis or infiltrative diseases (e.g. cardiac amyloidosis), HCM is still difficult to diagnose4.Ferroptosis, triggered by intracellular phospholipid peroxidation, plays an critical role in inflammation, while several antioxidants function as ferroptosis inhibitors to impede inflammations5,6. Ferroptosis was also associatedwith several metabolic pathways, for example, fatty acid metabolism, mitochondrial respiration and cell sensitivity to lipid peroxidation7–9. Glutathione/GPX4-independent axis inhibited ferroptosis via the regulation of iron and mitochondria9,10. Ferritinophagy, a type of ferritin-related autophagy, was triggered by iron overload, lipid peroxidation, membrane damage or cell death11. Hypoxia impeded ferritinophagy and increased mitochondrial ferritin and ferroptosis through NCOA4 expression and c-JUN regulation12,13. However, less researched were focused on the effects of ferroptosis and autophagy-related genes on HCM. In this study, the HCM-related dataset GSE89714 was analyzed, and ferroptosis- and autophagy-related DEGs were further explored. Hub genes were also identified. Quantitative polymerase chain reaction (qPCR) analysis was performed in the HCM mouse model and macrophage cell line to validate the hub gene effects on HCM progression. Results DEGs and functional enrichment analysis in GSE89714 Using the Limma package, 1,110 DEGs were identified in the GSE89714 dataset (Fig. 1 A; Figure S1), which were mainly enriched in extracellular matrix-receptor interactions, WP_IL18_SIGNALING_PATHWAY, KEGG_FOCAL_ADHESION, and KEGG_TGF_BETA_SIGNALING_PATHWAY (Fig. 1B–D; Table S1, S2). Fig. 1Identification of DEGs in the HCM GEO dataset. (A) The volcano plot of the dataset demonstrated distinguished features between hypertrophic myocardiopathy and control heart samples. (B) The significant GO and KEGG pathways of DEGs in GSE89714. (C-D) The GSEA pathways of DEGs in GSE89714. Identification of DEGs in the HCM GEO dataset. (A) The volcano plot of the dataset demonstrated distinguished features between hypertrophic myocardiopathy and control heart samples. (B) The significant GO and KEGG pathways of DEGs in GSE89714. (C-D) The GSEA pathways of DEGs in GSE89714. Ferroptosis- and autophagy-related DEGs and functional enrichment analysis Using Upset and Venn diagrams, 25 ferroptosis-related and 47 autophagy-related DEGs were identified (Fig. 2 A, B; Figure S2). They were mainly enriched in autophagy, ferroptosis, neurodegeneration pathways, multiple diseases, processes utilizing autophagic mechanisms, hijacked molecular function, and antioxidant activity (Fig. 2 C, D; Table S3). Fig. 2Identification of ferroptosis- and autophagy-related DEGs. (A) Upset diagram of GSE89714 DEGs as well as ferroptosis driver, inducer, inhibitor, marker and suppressor. (B) Venn diagram of GSE89714 DEGs and autophagy-related genes. (C-D) The bar plot (C) and network of the significant GO and KEGG pathways enriched by ferroptosis- and autophagy-related DEGs. Identification of ferroptosis- and autophagy-related DEGs. (A) Upset diagram of GSE89714 DEGs as well as ferroptosis driver, inducer, inhibitor, marker and suppressor. (B) Venn diagram of GSE89714 DEGs and autophagy-related genes. (C-D) The bar plot (C) and network of the significant GO and KEGG pathways enriched by ferroptosis- and autophagy-related DEGs. Protein-protein interaction (PPI) network analysis A PPI network was constructed (Fig. 3A). Using the Cytoscape plug-ins MCC and DMNC, the top 15 genes were identified, and using the Cytoscape plug-in MCODE, two modules were obtained (Fig. 3B–D). Fig. 3The PPI network construction. (A) The PPI network of ferroptosis- and autophagy-related DEGs. (B-C) The screened top15 genes using Cytoscape plugin DMNC (B) and MCC (C). (D) 3 modules were obtained using using Cytoscape plugin MCODE. The PPI network construction. (A) The PPI network of ferroptosis- and autophagy-related DEGs. (B-C) The screened top15 genes using Cytoscape plugin DMNC (B) and MCC (C). (D) 3 modules were obtained using using Cytoscape plugin MCODE. A Venn diagram was utilized to obtain the intersection among the top 15 MCC and DMNC genes. Three modules and the 10 screened genes, including BCL2L1, CD44, IGF1, CDKN1B, APP, CTNNB1, HMGB1, LAMP1, TFRC, and CXCR4, were named as hub genes, which were mainly involved in host interaction, transport vesicle, hijacked molecular function, HIF-1 signaling, and Autophagy–animal pathways (Fig. 4; Table S4). The transcription factor-hub gene network was also investigated (Figure S3). Fig. 4The hub genes and enrichment pathways. (A) Venn diagram of top15MCC genes, top15 DMNC genes and module genes. (B) The significant GO and KEGG pathways enriched by hub genes. (C) The PPI network of hub genes. The hub genes and enrichment pathways. (A) Venn diagram of top15MCC genes, top15 DMNC genes and module genes. (B) The significant GO and KEGG pathways enriched by hub genes. (C) The PPI network of hub genes. Hub gene validation The hub genes, including BCL2L1, CD44, IGF1, CDKN1B, APP, CTNNB1, HMGB1, LAMP1, TFRC, and CXCR4.To validate the effects of screened hub genes on macrophage, The macrophage hypoxia model was constructed 3% H2O2 was added to the macrophages at a ratio of 1:500.IGF1, CDKN1B, CTNNB1, HMGB1, LAMP1 and CXCR4 were highly expressed and BCL-2 and CD44 were lowly expressed for 4 h H2O2 treatment, while BCL-2, IGF1, CDKN1B, CTNNB1, HMGB1, LAMP1 and CXCR4 were highly expressed and CD44 lowly expressed for 8 h H2O2 treatment. There was no expression about APP and TFRC in macrophage hypoxia model, which may be other underlying mechanisms.Moreover, it is mentioning that the process of first decreasing and then increasing BCL-2 as an anti-apoptotic factor is also worthy of further study, (Fig. 5A). We conducted relevant protein verification, and the results confirmed that the expressions of LAMP1, CXCR4, and CDKN1B were all increased after 4 and 8 h H2O2 treatment, (Fig. 5B). Fig. 5qRT-PCR (A) and Western blottingresults (B) show the expression levels of ferroptosis-related and autophagy-related hub genes were validated in macrophage cell lines. The related mRNA and protein expression levels of screened hub genes. Two-way ANOVA were used for statistical analysis. The data are presented as the average ± SD of three independent experiments. *P < 0.05; **P < 0.01; ***P < 0.001; ns, not significant. qRT-PCR (A) and Western blottingresults (B) show the expression levels of ferroptosis-related and autophagy-related hub genes were validated in macrophage cell lines. The related mRNA and protein expression levels of screened hub genes. Two-way ANOVA were used for statistical analysis. The data are presented as the average ± SD of three independent experiments. *P < 0.05; **P < 0.01; ***P < 0.001; ns, not significant. To validate the effects of screened hub genes on HCM, HCM mice model was constructed (Fig. 6A; Figure S4). IGF1, CDKN1B, CTNNB1, HMGB1, LAMP1 and CXCR4 were highly expressed, and BCL-2 and CD44 were lowly expressed for 1w Isoproterenol Sulfate treatment. while BCL-2, IGF1, CDKN1B, CTNNB1, HMGB1, LAMP1 and CXCR4 were highly expressed and CD44 lowly expressed for 2w Isoproterenol Sulfate treatment. There was no expression about APP and TFRC in HCM mice model (Fig. 6E). We also performed a correlation analysis between EF values and mRNA levels. The results indicated that there was a negative correlation between EF values and mRNA levels for BCL-2, IGF1, CDKN1B, CTNNB1, HMGB1, LAMP1, and CXCR4. For CD44, there was a positive correlation between EF values and mRNA levels, (Fig. 6F). Fig. 6qRT-PCR results show the expression levels of ferroptosis-related and autophagy-related hub genes were validated in HCM mice model. (A-D) The representative images (A) and qualitative analysis (B-D) of mice treated with Isoproterenol Sulfate for 7 d or 14 d to induce HCM model. (E) The related mRNA levels of screened hub genes. Two-way ANOVA were used for statistical analysis.The data are presented as the average ± SD of three independent experiments. *P < 0.05; **P < 0.01; ***P < 0.001; ns, not significant. (F) Perform a correlation analysis between EF values and mRNA using the Pearson statistical method. qRT-PCR results show the expression levels of ferroptosis-related and autophagy-related hub genes were validated in HCM mice model. (A-D) The representative images (A) and qualitative analysis (B-D) of mice treated with Isoproterenol Sulfate for 7 d or 14 d to induce HCM model. (E) The related mRNA levels of screened hub genes. Two-way ANOVA were used for statistical analysis.The data are presented as the average ± SD of three independent experiments. *P < 0.05; **P < 0.01; ***P < 0.001; ns, not significant. (F) Perform a correlation analysis between EF values and mRNA using the Pearson statistical method. Single-cell sequencing analysis Using a single-cell portal, sequencing of hub gene expression demonstrated that the hub genes were highly expressed in macrophages in the human and HCM hearts (Figs. 7 and 8). Fig. 7The hub genes were highly expressed in macrophages in human heart. (A) The overall clustering of cells in human heart. (B-K) The hub genes were validated to be highly expressed in human heart, including BCL2L1 (B), CD44 (C), IGF1 (D), CDKN1B (E), APP (F), CTNNB1 (G), HMGB1 (H), LAMP1 (I), TFRC (J) and CXCR4 (K). The hub genes were highly expressed in macrophages in human heart. (A) The overall clustering of cells in human heart. (B-K) The hub genes were validated to be highly expressed in human heart, including BCL2L1 (B), CD44 (C), IGF1 (D), CDKN1B (E), APP (F), CTNNB1 (G), HMGB1 (H), LAMP1 (I), TFRC (J) and CXCR4 (K). Fig. 8The hub genes were highly expressed in macrophages in human HCM heart. (A) The overall clustering of cells in human heart. (B-K) The hub genes were validated to be highly expressed in human heart, including BCL2L1 (B), CD44 (C), IGF1 (D), CDKN1B (E), APP (F), CTNNB1 (G), HMGB1 (H), LAMP1 (I), TFRC (J) and CXCR4 (K). The hub genes were highly expressed in macrophages in human HCM heart. (A) The overall clustering of cells in human heart. (B-K) The hub genes were validated to be highly expressed in human heart, including BCL2L1 (B), CD44 (C), IGF1 (D), CDKN1B (E), APP (F), CTNNB1 (G), HMGB1 (H), LAMP1 (I), TFRC (J) and CXCR4 (K). Discussion The patients with HCM should be treated with comprehensive strategies, including screening of at-risk family members, pharmacological management of symptoms, and assessment and mitigation of risk of sudden death, including consideration of implantable cardioverter defibrillators14. Both echocardiogram and cardiac magnetic resonance imaging (MRI) are used to make a definitive diagnosis of HCM. HCM is also characterized by a distinct histopathological pattern with disarray in the overall architecture of the hypertrophied myocytes15. In addition to these imaging modalities, interrogation of family history, physical examination and genetic testing play critical roles in identifying patients with HCM. Approximately 60% of patients have a clearly recognizable familial disease, and various causal mutations in genes such as MYH7 and MYBPC3 have been identified. Zheng et al. reported ferroptosis and autophagy-related genes in the pathogenesis of ischemic cardiomyopathy and macrophage-related genes in the deterioration of cardiovascular diseases16–18. In this study, BCL2L1, CD44, IGF1, CDKN1B, APP, CTNNB1, HMGB1, LAMP1, TFRC, and CXCR4, were obtained and validated in HCM. In total, 6.7% (95% confidence interval 1.8–16.2%) of cats with HCM had an IGF-1 level > 1000 ng/ml. The prevalence of an IGF-1 level > 1000 ng/ml in the control group was zero19. IL6/adiponectin/HMGB1 feedback loop mediated adipocyte and macrophage crosstalk and M2 polarization after myocardial infarction and HCM mice model20. In addition, Aucubin protected against myocardial ischemia-reperfusion injury by regulating STAT3/NF-κB/HMGB-1 pathway21. Alpha-lipoic acid impeded myocardial ischemia-reperfusion injury, myocardial apoptosis, and oxidative stress by regulating HMGB1 expression and promoted M2b macrophage polarization after myocardial infarction via HMGB1/NF-kB signaling pathway22,23. RhoGDI-RhoGTPase signaling, integrin and ILK signaling pathways, the LXR/RXR pathway, and the PPARα/RXRα, HIF1α and CXCR4 pathways in the left ventricle showed particular importance in the HCM disease process24. Hypoxia induced the downregulation of miR-190a-3p in the culture medium of human cardiomyocytes, and exosomes of hypoxia-conditioned cardiomyocytes culture medium promoted the cell viability, proliferation, migration and adhesion via regulating miR-190a-3p/CXCR4/CXCL12 pathway25. In this study, BCL2L1, CD44, CDKN1B, APP, CTNNB1, LAMP1, and TFRC were demonstrated as ferroptosis and autophagy-related hub DEGs in HCM patients, which may be potential biomarkers and therapeutic targets for HCM progression. Some limitations should be mentioned. Firstly, there may be some false negatives because of the enrichment methods and PPI network analysis. The other neighbor genes are still needed to be investigated. Secondly, the sample sizes of included datasets were not too large, however, the results are highly reliable due to the previous reports. Thirdly, the lack of experiments on human samples of the disease and whether modulating the identified hub genes alters disease progression. Lastly, further researches are still needed to confirm the functional effects of the screened hub genes, such as BCL2L1, CD44, CDKN1B, APP, CTNNB1, LAMP1, and TFRC in HCM patients to improve the prognosis and prevent HCM progression and adverse events. There was no expression about APP and TFRC in macrophage hypoxia model, which may be other underlying mechanisms.Moreover, it is mentioning that the process of first decreasing and then increasing BCL2L1 as an anti-apoptotic factor is also worthy of further study. Overall, we performed bioinformatic analysis of ferroptosis- and autophagy-related DEGs to diagnose HCM and its progression. The screened hub genes, BCL2L1,CD44, IGF1, CDKN1B, APP, CTNNB1, HMGB1, LAMP1, TFRC and CXCR4, may be therapeutic targets for diagnosing HCM and its progression. Materials and methods Data source and data processing Utilizing the keywords “hypertrophic cardiomyopathy” in “homo sapiens”, GSE89714 was found. There are five samples from HCM and four from healthy donors. The DEGs were analyzed using the DESeq2 package. A log2|FC| > 1 and an adjusted P value < 0.05 were considered significant. Two datasets, including Ferroptosis Database (FerrDb; zhounan.org) and Autophagy Database (HAMdb; scbdd.com), were used to obtain the intersection with the HCM-related dataset. The intersected DEGs were named ferroptosis- and autophagy-related DEGs. Enrichment analyses Gene Ontology/Kyoto Encyclopedia of Genes and Genomes analysis and Gene Set Enrichment Analyses (GSEA) were carried out using R package gsea and clusterProfiler15,26,27. Statistical significance was set at P < 0.05 was considered significant. PPI network analysis and hub genes Using STRING (version 11)28 and the Cytoscape (version 3.7.1) plug-ins (MCC, DMNC, and degree)29, hub genes were obtained. Significant PPIs were screened with a combined score of > 0.4. Transcription factor-hub gene interactions were also constructed using NetworkAnalyst 3.0. Cell source and processing Select the macrophages30,31: RAW264.7 macrophages were cultured in a 6-well plate (5 × 10^5 cells per well) and maintained in a 37 °C normoxic incubator (5% CO2 and 95% air). The culture medium used was high-glucose Dulbecco’s modified Eagle’s complete medium (Gibco, USA), supplemented with 10% fetal bovine serum (AusgeneX, Australia) and 1% penicillin/streptomycin (Solarbio, China).For the treatment group, the complete medium was prepared as follows: 30% hydrogen peroxide solution with a concentration of 9.79 mol/L was first diluted 10-fold with methanol to obtain a working solution of 3% hydrogen peroxide at a concentration of 0.979 mol/L. Concentration gradient dilutions (1:5000, 1:2000, 1:1000, 1:500) were then set up for comparison. After 24 h of treatment, cell counting was performed. Compared with the group without hydrogen peroxide, the most significant difference in cell count was observed at the 1:1000 dilution. Therefore, the 1:1000 dilution was ultimately selected for treatment durations of 4 h and 8 h. Protein extraction and Western blotting Total protein was extracted using RIPA lysis buffer containing a protease and phosphatase inhibitor cocktail (Beyotime). Protein concentrations were determined using the BCA Protein Assay Kit (Pierce). Equal amounts of protein were separated by SDS-PAGE and transferred onto PVDF membranes. After blocking, the membranes were blocked at room temperature with 5% non-fat milk or BSA in TBST buffer for 1 h. The membranes were then incubated with the following primary antibodies: CDKN1B (Cat No. 25614-1-AP, dilution 1:1000), CXCR4 (Cat No. 60042-1-lg, dilution 1:1000, from Proteinch), and LAMP1 (Cat No. 21997-1-AP, dilution 1:1000) overnight at 4 °C. Next, the membranes were washed three times with TBST buffer for 5–10 min each time to remove unbound antibodies. Then, an appropriate HRP-conjugated secondary antibody was added, and incubated at room temperature for 1 h, followed by washing the membranes three more times with TBST buffer for 5–10 min each time. Finally, the bands were visualized using enhanced chemiluminescence (ECL) reagents (Millipore) and quantified by densitometry. Animals and mice model Adult experimental C57Bl/6J mice (male, 8 weeks, 20–24 g weight, 3–5 mice per cage) were purchased from Charles River (Beijing, China). The mice were maintained in a specific pathogen-free environment with free access to food and water and a 12/12 light–dark cycle. The HCM mouse model was constructed as previously described32–35. Carry out the modeling in two ways1: The animals were randomly assigned to four groups: (1) control (n = 4): ip. PBS 0.2 mL/20 g mouse weight, 7 d; (2) HCM (n = 5), ip. Isoproterenol Sulfate CRS 0.2 mL/20 g mouse weight, a dose of 30 mg/kg/day (Code I0600000, European Pharmacology) for 7 d; (3) control (n = 4): ip. PBS 0.2 mL/20 g mouse weight, 14 d; and (4) HCM (n = 5), ip. CRS 0.2 mL/20 g mouse weight at 30 mg/kg/day (Code I0600000; European Pharmacology) for 14 d2. The animals were randomly assigned to three groups: (1) control (n = 6): ip. Sham-operated animals, 28 d and 56 d; (2) HCM (n = 6), ip. transverse aortic constriction (TAC) for 28 d; (3) HCM (n = 6), ip. transverse aortic constriction (TAC) for 56 d. Briefly, the mice were anesthetized by intraper itoneal injection of 1% Tribromoethanol (0.2 ml/10 g) and ventilated with air. After opening the thoracic cavity and exposing the aortic arch, a 6 − 0 silk thread was passed between the left carotid and innominate artery and tied to a 27-gauge bluntted needle. The needle was then gently removed and the chest was closed. Sham-operated an imals underwent identical procedures without suture tightening. qPCR analysis To explore the effects of knockdown on macrophage polarization, qPCR of macrophages in different groups was performed using TRIzol and TB Green (TaKaRa, RR820). At 7 d and 14 d after HCM mouse model, quantitative real-time PCR of Heart samples was performed using TRIzol and TB Green to explore hub gene expression. B-actin was the reference gene, and the 2-ΔΔCt method was utilized. The correlation between mRNA levels and LVEF was determined. Fragments Sequence. BCL2L1 F: gccggagatagatttgaataacct R: cccggttgctctgagacatt. CD44 F: tcgatttgaatgtaacctgccg R: cagtccgggagatactgtagc. IGF1 F: ctggaccagagaccctttgc R: ggacggggacttctgagtctt. CDKN1B F: tcaaacgtgagagtgtctaacg R: ccgggccgaagagatttctg. APP F: ggtgctgagtcatcaagcatac R: gaacttcaacgtaggttgggaa. CTNNB1 F: atggagccggacagaaaagc R: cttgccactcagggaagga. HMGB1 F: ggcgagcatcctggcttatc R: ggctgcttgtcatctgctg. LAMP1 F: cagcactctttgaggtgaaaaac R: acgatctgagaaccattcgca. TFRC F: gtttctgccagcccccttattat R: gcaaggaaaggatatgcagca. CXCR4 F: cttctgggcagttgatgccat R: ctgttggttggcgtggacaat. Single-cell sequencing analysis Single-cell sequencing data were obtained from the Single Cell Portal (https://singlecell.broadinstitute.org/) to explore the hub gene expression in different cell lines (SCP498 and SCP1303)36,37. Statistical analysis All data were shown as mean ± SEM after normal distribution analysis. The Shapiro–Wilk normality test, Welch’s t-test (two groups), One-way ANOVA, and Two-way ANOVA were used for statistical analysis. Conduct correlation analysis using the Pearson statistical method. A multiple comparison P < 0.05 was considered significant. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 1 Supplementary Material 2 Supplementary Material 2 Supplementary Material 3 Supplementary Material 3